Rockwell Medical (RMTI) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Rockwell Medical Revenue Highlights

Latest Revenue (Y)

$83.61M

Latest Revenue (Q)

$25.83M

Main Segment (Y)

Concentrate Products

Main Geography (Y)

UNITED STATES

Rockwell Medical Revenue by Period

Rockwell Medical Revenue by Year

Date	Revenue	Change
2023-12-31	$83.61M	14.84%
2022-12-31	$72.81M	17.57%
2021-12-31	$61.93M	-0.43%
2020-12-31	$62.20M	1.46%
2019-12-31	$61.30M	-3.29%
2018-12-31	$63.39M	10.63%
2017-12-31	$57.30M	7.54%
2016-12-31	$53.28M	-3.73%
2015-12-31	$55.35M	2.14%
2014-12-31	$54.19M	3.45%
2013-12-31	$52.38M	5.09%
2012-12-31	$49.84M	1.79%
2011-12-31	$48.97M	-17.78%
2010-12-31	$59.55M	8.82%
2009-12-31	$54.73M	5.93%
2008-12-31	$51.67M	20.03%
2007-12-31	$43.05M	50.30%
2006-12-31	$28.64M	3.41%
2005-12-31	$27.69M	54.33%
2004-12-31	$17.94M	19.87%
2003-12-31	$14.97M	30.22%
2002-12-31	$11.50M	27.51%
2001-12-31	$9.02M	20.90%
2000-12-31	$7.46M	11.30%
1999-12-31	$6.70M	26.42%
1998-12-31	$5.30M	60.61%
1997-12-31	$3.30M	-

Rockwell Medical generated $83.61M in revenue during NA 2023, up 14.84% compared to the previous quarter, and up 131.90% compared to the same period a year ago.

Rockwell Medical Revenue by Quarter

Date	Revenue	Change
2024-06-30	$25.83M	13.92%
2024-03-31	$22.68M	2.64%
2023-12-31	$22.09M	-7.06%
2023-09-30	$23.77M	31.48%
2023-06-30	$18.08M	-8.07%
2023-03-31	$19.67M	1.84%
2022-12-31	$19.31M	3.33%
2022-09-30	$18.69M	0.05%
2022-06-30	$18.68M	15.86%
2022-03-31	$16.12M	5.17%
2021-12-31	$15.33M	-4.10%
2021-09-30	$15.99M	5.62%
2021-06-30	$15.14M	-2.17%
2021-03-31	$15.47M	2.04%
2020-12-31	$15.16M	-0.76%
2020-09-30	$15.28M	-3.88%
2020-06-30	$15.90M	0.25%
2020-03-31	$15.86M	2.36%
2019-12-31	$15.49M	0.54%
2019-09-30	$15.41M	3.78%
2019-06-30	$14.85M	-4.59%
2019-03-31	$15.56M	-7.68%
2018-12-31	$16.85M	1.09%
2018-09-30	$16.67M	11.80%
2018-06-30	$14.91M	-0.24%
2018-03-31	$14.95M	0.75%
2017-12-31	$14.84M	1.44%
2017-09-30	$14.63M	10.45%
2017-06-30	$13.24M	-9.25%
2017-03-31	$14.59M	8.98%
2016-12-31	$13.39M	4.49%
2016-09-30	$12.81M	-4.74%
2016-06-30	$13.45M	-1.28%
2016-03-31	$13.63M	-3.58%
2015-12-31	$14.13M	-1.71%
2015-09-30	$14.38M	10.98%
2015-06-30	$12.96M	-6.69%
2015-03-31	$13.88M	-3.90%
2014-12-31	$14.45M	5.12%
2014-09-30	$13.74M	5.45%
2014-06-30	$13.03M	0.54%
2014-03-31	$12.96M	-7.17%
2013-12-31	$13.96M	6.65%
2013-09-30	$13.09M	0.85%
2013-06-30	$12.98M	5.25%
2013-03-31	$12.34M	-5.10%
2012-12-31	$13.00M	2.45%
2012-09-30	$12.69M	4.66%
2012-06-30	$12.12M	0.80%
2012-03-31	$12.03M	1.11%
2011-12-31	$11.90M	-0.66%
2011-09-30	$11.98M	1.47%
2011-06-30	$11.80M	-11.20%
2011-03-31	$13.29M	-7.20%
2010-12-31	$14.32M	-2.87%
2010-09-30	$14.75M	-4.91%
2010-06-30	$15.51M	3.52%
2010-03-31	$14.98M	1.48%
2009-12-31	$14.76M	4.26%
2009-09-30	$14.16M	8.80%
2009-06-30	$13.01M	1.69%
2009-03-31	$12.80M	-5.47%
2008-12-31	$13.54M	0.03%
2008-09-30	$13.53M	11.10%
2008-06-30	$12.18M	-1.85%
2008-03-31	$12.41M	3.88%
2007-12-31	$11.95M	-

Rockwell Medical generated $25.83M in revenue during Q2 2024, up 13.92% compared to the previous quarter, and up 131.34% compared to the same period a year ago.

Rockwell Medical Revenue Breakdown

Rockwell Medical Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Drug Revenue	$2.34M	-	-	-	-
Concentrate Products	$81.27M	-	-	-	-
Upfront Fee	-	$2.50M	$1.90M	$2.00M	-
Product	-	-	-	-	$59.00M
License	-	-	-	-	$2.30M

Rockwell Medical's latest annual revenue breakdown by segment (product or service), as of Dec 23: Concentrate Products (97.20%), and Drug Revenue (2.80%).

Quarterly Revenue by Product

Product/Service	Sep 24	Mar 24	Dec 23	Sep 23	Dec 18
Concentrate Products	$28.30M	$22.66M	$59.70M	$21.57M	$16.79M
Drug Revenue	$11.00K	$11.00K	$141.00K	$2.20M	$68.00K

Rockwell Medical's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Concentrate Products (99.96%), and Drug Revenue (0.04%).

Rockwell Medical Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
UNITED STATES	$74.34M	$561.00K	$835.00K	$910.00K	$272.00K
Non-US	$9.27M	$598.00K	$241.00K	$226.00K	$273.00K

Rockwell Medical's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (88.91%), and Non-US (11.09%).

Quarterly Revenue by Country

Country	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
UNITED STATES	$26.25M	$20.93M	$54.60M	$19.74M	-	-	-	$193.00K	$209.00K	$159.00K	$179.00K	$217.00K	$215.00K	$225.00K	$301.00K	$228.00K	$182.00K	$199.00K	$13.94M	-
Non-US	$2.07M	$1.74M	$5.11M	$4.03M	$65.00K	$65.00K	$133.00K	$65.00K	$338.00K	$62.00K	$62.00K	$62.00K	$58.00K	$58.00K	$59.00K	$56.00K	$56.00K	$56.00K	$1.33M	-
Non Us	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$1.46M
U	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$13.85M

Rockwell Medical's latest quarterly revenue breakdown by geography, as of Sep 24: UNITED STATES (92.69%), and Non-US (7.31%).

Rockwell Medical Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
PAHC	Phibro Animal Health	$977.89M	$273.16M
COLL	Collegium Pharmaceutical	$566.77M	$159.30M
ANIP	ANI Pharmaceuticals	$486.82M	$148.33M
ITCI	Intra-Cellular Therapies	$462.18M	$175.38M
PROC	Procaps Group	$409.92M	$118.41M
KMDA	Kamada	$144.76M	$37.40M
LFCR	Lifecore Biomedical	$128.26M	$24.70M
RMTI	Rockwell Medical	$83.61M	$25.83M
AQST	Aquestive Therapeutics	$50.58M	$13.54M
CPIX	Cumberland Pharmaceuticals	$39.55M	$9.09M
BFRI	Biofrontera	$34.01M	$7.83M
EVOK	Evoke Pharma	$5.18M	$2.65M
SXTC	China SXT Pharmaceuticals	$1.97M	$939.58K
IXHL	Incannex Healthcare	-	$12.00K
RGC	Regencell Bioscience	-	-

RMTI Revenue FAQ

What is Rockwell Medical’s yearly revenue?

Rockwell Medical's yearly revenue for 2023 was $83.61M, representing an increase of 14.84% compared to 2022. The company's yearly revenue for 2022 was $72.81M, representing an increase of 17.57% compared to 2021. RMTI's yearly revenue for 2021 was $61.93M, representing a decrease of -0.43% compared to 2020.

What is Rockwell Medical’s quarterly revenue?

Rockwell Medical's quarterly revenue for Q2 2024 was $25.83M, a 13.92% increase from the previous quarter (Q1 2024), and a 42.88% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $22.68M, a 2.64% increase from the previous quarter (Q4 2023), and a 15.29% increase year-over-year (Q1 2023). RMTI's quarterly revenue for Q4 2023 was $22.09M, a -7.06% decrease from the previous quarter (Q3 2023), and a 14.39% increase year-over-year (Q4 2022).

What is Rockwell Medical’s revenue growth rate?

Rockwell Medical's revenue growth rate for the last 3 years (2021-2023) was 35.01%, and for the last 5 years (2019-2023) was 36.39%.

What are Rockwell Medical’s revenue streams?

Rockwell Medical's revenue streams in c 23 are Drug Revenue, and Concentrate Products. Drug Revenue generated $2.34M in revenue, accounting 2.80% of the company's total revenue Concentrate Products generated $81.27M in revenue, accounting 97.20% of the company's total revenue

What is Rockwell Medical’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Rockwell Medical was Concentrate Products. This segment made a revenue of $81.27M, representing 97.20% of the company's total revenue.